Fifth Lane Capital »

Reneo Pharmaceuticals shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $54k 33k 1.66
2023-12-31 $64k 40k 1.60

More positions owned by Fifth Lane Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Callon Petroleum (CPE)
Capri Holdings SHS (CPRI)
Axonics Modulation Technolog (AXNX)
Enviva Call Option (EVA)
Vizio Hldg Corp Cl A Com (VZIO)
Ib Acquisition Corp Unit 03/26/2029
3M Company Put Option (MMM)
Walt Disney Company (DIS)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Star Bulk Carriers Corp. Shs Par (SBLK)
Altc Acquisition Corp Com Cl A Call Option (ALCC)
McGrath Rent (MGRC)
Brookfield Renewable Corp Cl A Sub Vtg (BEPC)
Atlantic Union B (AUB)

View all positions for Fifth Lane Capital

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Highbridge Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
Ikarian Capital
BlackRock
Vanguard Group
Aisling Capital Management
Caption Management
Acuitas Investments
Geode Capital Management
Two Sigma Investments

View all funds holding Reneo Pharmaceuticals